742 related articles for article (PubMed ID: 18922152)
1. Targeting aspartate aminotransferase in breast cancer.
Thornburg JM; Nelson KK; Clem BF; Lane AN; Arumugam S; Simmons A; Eaton JW; Telang S; Chesney J
Breast Cancer Res; 2008; 10(5):R84. PubMed ID: 18922152
[TBL] [Abstract][Full Text] [Related]
2. Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells.
Liu X; Yang Z; Chen Z; Chen R; Zhao D; Zhou Y; Qiao L
Oncol Rep; 2015 Jan; 33(1):157-62. PubMed ID: 25394466
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the low inhibitory specificity of oxamate, aminooxyacetate and dichloroacetate on cancer energy metabolism.
Moreno-Sánchez R; Marín-Hernández Á; Del Mazo-Monsalvo I; Saavedra E; Rodríguez-Enríquez S
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3221-3236. PubMed ID: 27538376
[TBL] [Abstract][Full Text] [Related]
4. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
[TBL] [Abstract][Full Text] [Related]
5. Effective inhibition of nasopharyngeal carcinoma in vitro and in vivo by targeting glycolysis with oxamate.
Li X; Lu W; Hu Y; Wen S; Qian C; Wu W; Huang P
Int J Oncol; 2013 Nov; 43(5):1710-8. PubMed ID: 23982861
[TBL] [Abstract][Full Text] [Related]
6. Metabolic consequences of lactate dehydrogenase inhibition by oxamate in hyperglycemic proximal tubular cells.
Wang Z; Nielsen PM; Laustsen C; Bertelsen LB
Exp Cell Res; 2019 May; 378(1):51-56. PubMed ID: 30836064
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
[TBL] [Abstract][Full Text] [Related]
8. Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression.
Chaube B; Malvi P; Singh SV; Mohammad N; Meena AS; Bhat MK
Oncotarget; 2015 Nov; 6(35):37281-99. PubMed ID: 26484566
[TBL] [Abstract][Full Text] [Related]
9. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
10. Measurement of aspartate aminotransferase activity: effects of oxamate.
Rej R
Clin Chem; 1979 Apr; 25(4):555-9. PubMed ID: 466765
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of LDH-A by oxamate induces G2/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells.
Zhai X; Yang Y; Wan J; Zhu R; Wu Y
Oncol Rep; 2013 Dec; 30(6):2983-91. PubMed ID: 24064966
[TBL] [Abstract][Full Text] [Related]
12. Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene.
Kong Y; Lu ZL; Wang JJ; Zhou R; Guo J; Liu J; Sun HL; Wang H; Song W; Yang J; Xu HX
Oncol Rep; 2016 Sep; 36(3):1447-56. PubMed ID: 27432230
[TBL] [Abstract][Full Text] [Related]
13. Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines.
Fiume L; Manerba M; Vettraino M; Di Stefano G
Pharmacology; 2010; 86(3):157-62. PubMed ID: 20699632
[TBL] [Abstract][Full Text] [Related]
14. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.
Farabegoli F; Vettraino M; Manerba M; Fiume L; Roberti M; Di Stefano G
Eur J Pharm Sci; 2012 Nov; 47(4):729-38. PubMed ID: 22954722
[TBL] [Abstract][Full Text] [Related]
15. Oxamate potentiates taxol chemotherapeutic efficacy in experimentally-induced solid ehrlich carcinoma (SEC) in mice.
El-Sisi AE; Sokar SS; Abu-Risha SE; El-Mahrouk SR
Biomed Pharmacother; 2017 Nov; 95():1565-1573. PubMed ID: 28950656
[TBL] [Abstract][Full Text] [Related]
16. Synergistic anti-cancer effect of phenformin and oxamate.
Miskimins WK; Ahn HJ; Kim JY; Ryu S; Jung YS; Choi JY
PLoS One; 2014; 9(1):e85576. PubMed ID: 24465604
[TBL] [Abstract][Full Text] [Related]
17. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
[TBL] [Abstract][Full Text] [Related]
18. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
19. Coadministration of nanosystems of short silencing RNAs targeting oestrogen receptor alpha and anti-oestrogen synergistically induces tumour growth inhibition in human breast cancer xenografts.
Bouclier C; Marsaud V; Bawa O; Nicolas V; Moine L; Opolon P; Renoir JM
Breast Cancer Res Treat; 2010 Jul; 122(1):145-58. PubMed ID: 19771505
[TBL] [Abstract][Full Text] [Related]
20. Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate.
Korangath P; Teo WW; Sadik H; Han L; Mori N; Huijts CM; Wildes F; Bharti S; Zhang Z; Santa-Maria CA; Tsai H; Dang CV; Stearns V; Bhujwalla ZM; Sukumar S
Clin Cancer Res; 2015 Jul; 21(14):3263-73. PubMed ID: 25813021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
